L. Kueltzo

发表

Characterization of synthetic gene delivery vectors by infrared spectroscopy.

C. Russell Middaugh, S. Choosakoonkriang, C. Wiethoff, 2001, Methods in molecular medicine.

Ultraviolet absorption and circular dichroism spectroscopy of nonviral gene delivery complexes.

C. Russell Middaugh, C. Braun, L. Kueltzo, 2001, Methods in molecular medicine.

Molten Globule-Lipid Bilayer Interactions and Their Implications for Protein Transport and Aggregation

C. R. Middaugh, L. Kueltzo, C. Middaugh, 2006 .

Nonclassical transport proteins and peptides: an alternative to classical macromolecule delivery systems.

C. R. Middaugh, L. Kueltzo, C. Middaugh, 2003, Journal of pharmaceutical sciences.

Potential use of non-classical pathways for the transport of macromolecular drugs

C. R. Middaugh, L. Kueltzo, C R Middaugh, 2000, Expert opinion on investigational drugs.

Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetry.

E. Freire, A. Schön, L. Kueltzo, 2018, Analytical biochemistry.

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody

J. Mascola, E. Reinherz, G. Chuang, 2018, Cell reports.

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.

J. Mascola, R. Bailer, B. Graham, 2021, The Lancet. Respiratory medicine.

A proof of concept for structure-based vaccine design targeting RSV in humans

J. Mascola, P. Kwong, B. Graham, 2019, Science.

Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant.

J. Mascola, M. Sastry, I. Georgiev, 2016, Bioconjugate chemistry.

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

J. Mascola, G. Chuang, Reda Rawi, 2020, Scientific Reports.

Title Conformational Lability of Herpes Virus Protein VP 22 Authors

P. O’Hare, L. Kueltzo, C. Middaugh, 2000 .

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

J. Mascola, G. Chuang, Baoshan Zhang, 2020, mAbs.

A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development.

S. Joshi, D. Volkin, R. Schwartz, 2016, Journal of pharmaceutical sciences.

Probing protein structure and dynamics by second‐derivative ultraviolet absorption analysis of cation–π interactions

L. Peek, S. Joshi, L. Kueltzo, 2006, Protein science : a publication of the Protein Society.

Complex effects of molecular chaperones on the aggregation and refolding of fibroblast growth factor-1.

K. Edwards, L. Kueltzo, M. Fisher, 2001, Archives of biochemistry and biophysics.

Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine

J. Mascola, B. Graham, Geoffrey B. Hutchinson, 2021, Frontiers in Immunology.

Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development

J. Mascola, B. Graham, Geoffrey B. Hutchinson, 2020, Frontiers in Immunology.

Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing.

J. Carpenter, L. Kueltzo, T. Randolph, 2008, Journal of pharmaceutical sciences.

Structure-Function Analysis of Invasion Plasmid Antigen C (IpaC) from Shigella flexneri *

L. Kueltzo, W. Picking, J. Osiecki, 2003, The Journal of Biological Chemistry.

Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study.

C Russell Middaugh, L. Kueltzo, J. Ralston, 2003, Journal of pharmaceutical sciences.

Characterization of VP22 in Herpes Simplex Virus-Infected Cells

J. McLauchlan, P. O’Hare, L. Kueltzo, 2005, Journal of Virology.

Characterization of VP 22 in Herpes Simplex Virus-Infected Cells

J. McLauchlan, P. O’Hare, L. Kueltzo, 2005 .

Conformational Lability of Herpesvirus Protein VP22*

P. O’Hare, L. Kueltzo, C R Middaugh, 2000, The Journal of Biological Chemistry.

Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.

C Russell Middaugh, Sangeeta B Joshi, David B Volkin, 2013, Journal of pharmaceutical sciences.

Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate.

S. Joshi, D. Volkin, R. Schwartz, 2018, Journal of pharmaceutical sciences.

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.

Zonghui Hu, A. McDermott, J. Gall, 2023, The Lancet. Infectious diseases.

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Carmen M. Graves, J. Mascola, R. Koup, 2023, Science Translational Medicine.

A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development.

S. Joshi, D. Volkin, L. Kueltzo, 2016, Journal of pharmaceutical sciences.